Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients

Edaravone ALS Study Group

Research output: Contribution to journalArticle

143 Citations (Scopus)

Fingerprint Dive into the research topics of 'Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients'. Together they form a unique fingerprint.

Medicine & Life Sciences